A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy
There is no effective treatment for advanced extramammary Paget's disease (EMPD). The human epidermal growth factor receptor 2 (HER2) protein is often overexpressed in EMPD. Trastuzumab is a humanized monoclonal antibody against HER2 used in the treatment of breast cancers in which HER2 is over...
Saved in:
Main Authors: | Fumie Hanawa (Author), Takashi Inozume (Author), Kazutoshi Harada (Author), Tatsuyosi Kawamura (Author), Naotaka Shibagaki (Author), Shinji Shimada (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2011-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget's Disease to Trastuzumab Monotherapy
by: S. Wakabayashi, et al.
Published: (2012) -
Extramammary Paget's disease with ureteral metastasis: A case report
by: Shunsuke Nakamura, et al.
Published: (2024) -
Mammary and extramammary Paget's disease
by: Lauro Lourival Lopes Filho, et al.
Published: (2015) -
Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget's Disease
by: Mariko Urano-Takaoka, et al.
Published: (2022) -
Ado-trastuzumab emtansine (T-DM1) for a case of HER2-amplified metastatic extramammary Paget's disease of scrotum: Clinical next-generation sequencing for precision medicine
by: Chih-Yu Chen, et al.
Published: (2020)